{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T04:58:16Z","timestamp":1794977896769,"version":"4.9.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["22078111"],"award-info":[{"award-number":["22078111"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Guangdong Province Key Areas Research and Development Plan project","award":["2023B0202030002"],"award-info":[{"award-number":["2023B0202030002"]}]},{"name":"Guangzhou Science and Technology Planning Project","award":["2023B01J2004"],"award-info":[{"award-number":["2023B01J2004"]}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","award":["2022ZYGXZR102"],"award-info":[{"award-number":["2022ZYGXZR102"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Naringenin (NAR) possesses various pharmacological activities including antioxidant, anti-inflammatory, and hepatoprotective effects. However, its therapeutic efficacy is limited by its hydrophobic and crystalline nature. This study aimed to investigate the therapeutic potential and molecular mechanisms of NAR efficiently loaded into cationic nanoparticles (NP-NAR) for treating metabolic dysfunction-associated steatotic liver disease (MASLD) in a mouse model. The results demonstrated that NP-NAR effectively ameliorated lipid metabolism dysbiosis, oxidative stress, insulin resistance, and inflammation in MASLD mice. Transcriptomic analysis and molecular data revealed that NP-NAR promoted fatty acid oxidation via activation of the PPAR signaling pathway, reduced hepatic lipid uptake and lipogenesis by inhibiting the expressions of key genes including CD36, ACC, and FASN. Moreover, NP-NAR modulated cholesterol metabolism by inhibiting the classical bile acid synthesis pathway. 16\u00a0S rDNA gene sequencing revealed a disbalanced gut microbiota in MASLD mice, whereas NP-NAR treatment statistically reversed the abundance changes of several intestinal bacteria at the phylum and genus levels, which partly contributed to the balance in intestinal metabolite production, including short-chain fatty acids. In conclusion, these findings suggest that NP-NAR may be a promising candidate for the treatment of obesity-associated MASLD, offering new insight into the mechanisms underlying NAR\u2019s efficacy against MASLD.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1186\/s12951-025-03228-x","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T09:50:38Z","timestamp":1741081838000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Naringenin cationic lipid-modified nanoparticles mitigate MASLD progression by modulating lipid homeostasis and gut microbiota"],"prefix":"10.1186","volume":"23","author":[{"given":"Lu","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyong","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congfei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"key":"3228_CR1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev-pathol-020117-043617","volume":"13","author":"JP Arab","year":"2018","unstructured":"Arab JP, Arrese M, Trauner M. Recent insights into the pathogenesis of nonalcoholic fatty liver disease. Annu Rev Pathol. 2018;13:13:321\u201350.","journal-title":"Annu Rev Pathol"},{"key":"3228_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3322\/caac.21499","volume":"69","author":"H Sung","year":"2019","unstructured":"Sung H, Siegel RL, Torre LA, Pearson-Stuttard J, Islami F, Fedewa SA, Sauer AG, Shuval K, Gapstur SM, Jacobs EJ, et al. Global patterns in excess body weight and the associated cancer burden. CA-A CANCER J Clin. 2019;69:88\u2013112.","journal-title":"CA-A CANCER J Clin"},{"key":"3228_CR3","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24:908\u201322.","journal-title":"Nat Med"},{"key":"3228_CR4","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1016\/S0140-6736(19)32963-0","volume":"394","author":"M Eslam","year":"2019","unstructured":"Eslam M, Alvani R, Shiha G. Obeticholic acid: towards first approval for NASH. Lancet. 2019;394:2131\u20133.","journal-title":"Lancet"},{"key":"3228_CR5","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa2306185","volume":"390","author":"KV Kowdley","year":"2024","unstructured":"Kowdley KV, Bowlus CL, Levy C, Akarca US, Alvares-da-Silva MR, Andreone P, Arrese M, Corpechot C, Francque SM, Heneghan MA, et al. Efficacy and safety of Elafibranor in primary biliary cholangitis. N Engl J Med. 2024;390:795\u2013805.","journal-title":"N Engl J Med"},{"key":"3228_CR6","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/13543784.2018.1442436","volume":"27","author":"F Tacke","year":"2018","unstructured":"Tacke F. Cenicriviroc for the treatment of non-alcoholic steatohepatitis and liver fibrosis. Expert Opin Investig Drugs. 2018;27:301\u201311.","journal-title":"Expert Opin Investig Drugs"},{"key":"3228_CR7","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1111\/bph.14938","volume":"177","author":"Q Wang","year":"2020","unstructured":"Wang Q, Ou Y, Hu G, Wen C, Yue S, Chen C, Xu L, Xie J, Dai H, Xiao H, et al. Naringenin attenuates non-alcoholic fatty liver disease by down-regulating the NLRP3\/NF-\u03baB pathway in mice. Br J Pharmacol. 2020;177:1806\u201321.","journal-title":"Br J Pharmacol"},{"key":"3228_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.lfs.2018.07.017","volume":"208","author":"NH Zaidun","year":"2018","unstructured":"Zaidun NH, Thent ZC, Latiff AA. Combating oxidative stress disorders with citrus flavonoid: Naringenin. Life Sci. 2018;208:111\u201322.","journal-title":"Life Sci"},{"key":"3228_CR9","doi-asserted-by":"publisher","first-page":"120752","DOI":"10.1016\/j.lfs.2022.120752","volume":"305","author":"M Motallebi","year":"2022","unstructured":"Motallebi M, Bhia M, Rajani HF, Bhia I, Tabarraei H, Mohammadkhani N, Pereira-Silva M, Kasaii MS, Nouri-Majd S, Mueller A-L, et al. Naringenin: a potential flavonoid phytochemical for cancer therapy. Life Sci. 2022;305:120752.","journal-title":"Life Sci"},{"key":"3228_CR10","doi-asserted-by":"crossref","unstructured":"Den Hartogh DJ, Tsiani E. Antidiabetic properties of naringenin: a citrus fruit polyphenol. Biomolecules. 2019;9:99.","DOI":"10.3390\/biom9030099"},{"key":"3228_CR11","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.nutres.2004.07.005","volume":"24","author":"I Erlund","year":"2004","unstructured":"Erlund I. Review of the flavonoids quercetin, hesperetin, and naringenin. Dietary sources, bioactivities, bioavailability, and epidemiology. Nutr Res. 2004;24:851\u201374.","journal-title":"Nutr Res"},{"key":"3228_CR12","doi-asserted-by":"publisher","first-page":"1900055","DOI":"10.1002\/smll.201900055","volume":"15","author":"C-F Xu","year":"2019","unstructured":"Xu C-F, Iqbal S, Shen S, Luo Y-L, Yang X, Wang J. Development of CLAN Nanomedicine for Nucleic Acid therapeutics. Small. 2019;15:1900055.","journal-title":"Small"},{"key":"3228_CR13","doi-asserted-by":"publisher","first-page":"7445","DOI":"10.1039\/D3BM01469J","volume":"11","author":"X Huang","year":"2023","unstructured":"Huang X, Li J, Yang Y, Wang Z-L, Yang X-Z, Lu Z-D, Xu C-F. Lipid-assisted PEG-b-PLA nanoparticles with ultrahigh SN38 loading capability for efficient cancer therapy. BIOMATERIALS Sci. 2023;11:7445\u201357.","journal-title":"BIOMATERIALS Sci"},{"key":"3228_CR14","doi-asserted-by":"publisher","first-page":"8600","DOI":"10.1016\/j.biomaterials.2012.08.008","volume":"33","author":"JS Park","year":"2012","unstructured":"Park JS, Yang HN, Jeon SY, Woo DG, Kim MS, Park K-H. The use of anti-COX2 siRNA coated onto PLGA nanoparticles loading dexamethasone in the treatment of rheumatoid arthritis. Biomaterials. 2012;33:8600\u201312.","journal-title":"Biomaterials"},{"key":"3228_CR15","doi-asserted-by":"publisher","first-page":"4955","DOI":"10.1021\/nn300500u","volume":"6","author":"X-Z Yang","year":"2012","unstructured":"Yang X-Z, Dou S, Wang Y-C, Long H-Y, Xiong M-H, Mao C-Q, Yao Y-D, Wang J. Single-step assembly of Cationic lipid-polymer hybrid nanoparticles for systemic delivery of siRNA. ACS Nano. 2012;6:4955\u201365.","journal-title":"ACS Nano"},{"key":"3228_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biomaterials.2015.01.068","volume":"51","author":"C-F Xu","year":"2015","unstructured":"Xu C-F, Liu Y, Shen S, Zhu Y-H, Wang J. Targeting glucose uptake with siRNA-based nanomedicine for cancer therapy. Biomaterials. 2015;51:1\u201311.","journal-title":"Biomaterials"},{"key":"3228_CR17","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1515\/mr-2022-0047","volume":"3","author":"Y-N Fan","year":"2023","unstructured":"Fan Y-N, Zhao G, Zhang Y, Ye Q-N, Sun Y-Q, Shen S, Liu Y, Xu C-F, Wang J. Progress in nanoparticle-based regulation of immune cells. Med Rev (2021). 2023;3:152\u201379.","journal-title":"Med Rev (2021)"},{"key":"3228_CR18","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.jhep.2022.12.028","volume":"78","author":"Y Yin","year":"2023","unstructured":"Yin Y, Sichler A, Ecker J, Laschinger M, Liebisch G, H\u00f6ring M, Basic M, Bleich A, Zhang XJ, K\u00fcbelsbeck L, et al. Gut microbiota promote liver regeneration through hepatic membrane phospholipid biosynthesis. J Hepatol. 2023;78:820\u201335.","journal-title":"J Hepatol"},{"key":"3228_CR19","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1136\/gutjnl-2021-326789","volume":"71","author":"MV Willem","year":"2022","unstructured":"Willem MV, Herbert T, Matthias Van H, Patrice DC. Gut microbiome and health: mechanistic insights. Gut. 2022;71:1020.","journal-title":"Gut"},{"key":"3228_CR20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41423-020-00592-6","volume":"18","author":"R Wang","year":"2021","unstructured":"Wang R, Tang R, Li B, Ma X, Schnabl B, Tilg H. Gut microbiome, liver immunology, and liver diseases. Cell Mol Immunol. 2021;18:4\u201317.","journal-title":"Cell Mol Immunol"},{"key":"3228_CR21","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1053\/j.gastro.2021.11.006","volume":"162","author":"B Chassaing","year":"2022","unstructured":"Chassaing B, Compher C, Bonhomme B, Liu Q, Tian Y, Walters W, Nessel L, Delaroque C, Hao F, Gershuni V, et al. Randomized controlled-feeding study of Dietary Emulsifier Carboxymethylcellulose reveals detrimental impacts on the gut microbiota and Metabolome. Gastroenterology. 2022;162:743\u201356.","journal-title":"Gastroenterology"},{"key":"3228_CR22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jconrel.2011.07.035","volume":"156","author":"X-Z Yang","year":"2011","unstructured":"Yang X-Z, Dou S, Sun T-M, Mao C-Q, Wang H-X, Wang J. Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy. J Controlled Release. 2011;156:203\u201311.","journal-title":"J Controlled Release"},{"key":"3228_CR23","doi-asserted-by":"publisher","first-page":"138346","DOI":"10.1016\/j.foodchem.2023.138346","volume":"441","author":"X Xu","year":"2024","unstructured":"Xu X, Ye A, Zhang T, Pan Y, Jiang H, Deng L, Qin Y, Li J, Han J, Liu W. The novel lactoferrin and DHA-codelivered liposomes with different membrane structures: fabrication, in vitro infant digestion, and suckling pig intestinal organoid absorption. Food Chem. 2024;441:138346.","journal-title":"Food Chem"},{"key":"3228_CR24","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313\u201321.","journal-title":"Hepatology"},{"key":"3228_CR25","doi-asserted-by":"publisher","first-page":"104394","DOI":"10.1016\/j.jff.2021.104394","volume":"79","author":"X Zhou","year":"2021","unstructured":"Zhou X, Xiang X, Zhou Y, Zhou T, Deng S, Zheng B, Zheng P. Protective effects of Antarctic krill oil in dextran sulfate sodium-induced ulcerative colitis mice. J Funct Foods. 2021;79:104394.","journal-title":"J Funct Foods"},{"key":"3228_CR26","doi-asserted-by":"publisher","first-page":"7884","DOI":"10.1021\/acs.jafc.1c02257","volume":"69","author":"C Xue","year":"2021","unstructured":"Xue C, Li Y, Lv H, Zhang L, Bi C, Dong N, Shan A, Wang J. Oleanolic acid targets the Gut-Liver Axis to Alleviate Metabolic disorders and Hepatic Steatosis. J Agric Food Chem. 2021;69:7884\u201397.","journal-title":"J Agric Food Chem"},{"key":"3228_CR27","doi-asserted-by":"publisher","first-page":"14732","DOI":"10.1021\/acs.jafc.2c06212","volume":"70","author":"S Zunji","year":"2022","unstructured":"Zunji S, Ce Z, Hehua L, Chuan C, Zheng C, Yuchen S, Gui C, Fang W, Jinlin Z, Yujing L, Limin Z. Structural insights into amelioration effects of quercetin and its glycoside derivatives on NAFLD in mice by modulating the gut microbiota and host metabolism. J Agric Food Chem. 2022;70:14732\u201343.","journal-title":"J Agric Food Chem"},{"key":"3228_CR28","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/nrd2614","volume":"7","author":"ME Davis","year":"2008","unstructured":"Davis ME, Chen Z, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discovery. 2008;7:771\u201382.","journal-title":"Nat Rev Drug Discovery"},{"key":"3228_CR29","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41569-021-00541-4","volume":"18","author":"A Pirillo","year":"2021","unstructured":"Pirillo A, Casula M, Olmastroni E, Norata GD, Catapano AL. Global epidemiology of dyslipidaemias. Nat Reviews Cardiol. 2021;18:689\u2013700.","journal-title":"Nat Reviews Cardiol"},{"key":"3228_CR30","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1002\/ptr.5667","volume":"30","author":"M Akhlaghi","year":"2016","unstructured":"Akhlaghi M. Non-alcoholic fatty liver disease: Beneficial effects of flavonoids. Phytother Res. 2016;30:1559\u201371.","journal-title":"Phytother Res"},{"key":"3228_CR31","doi-asserted-by":"crossref","unstructured":"Masarone M, Rosato V, Dallio M, Gravina AG, Aglitti A, Loguercio C, Federico A, Persico M. Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease. Oxidative Medicine and Cellular Longevity 2018, 2018:9547613.","DOI":"10.1155\/2018\/9547613"},{"key":"3228_CR32","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1159\/000485089","volume":"44","author":"L He","year":"2017","unstructured":"He L, He T, Farrar S, Ji L, Liu T, Ma X. Antioxidants Maintain Cellular Redox Homeostasis by Elimination of reactive oxygen species. Cell Physiol Biochem. 2017;44:532\u201353.","journal-title":"Cell Physiol Biochem"},{"key":"3228_CR33","doi-asserted-by":"publisher","first-page":"106786","DOI":"10.1016\/j.phrs.2023.106786","volume":"192","author":"Y-Y Qiu","year":"2023","unstructured":"Qiu Y-Y, Zhang J, Zeng F-Y, Zhu YZ. Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). Pharmacol Res. 2023;192:106786.","journal-title":"Pharmacol Res"},{"key":"3228_CR34","doi-asserted-by":"publisher","first-page":"5576","DOI":"10.1039\/D0FO03028G","volume":"12","author":"M Ji","year":"2021","unstructured":"Ji M, Fang C, Jia W, Du H, Xu Y. Regulatory effect of volatile compounds in fermented alcoholic beverages on gut microbiota and serum metabolism in a mouse model. Food Funct. 2021;12:5576\u201390.","journal-title":"Food Funct"},{"key":"3228_CR35","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1002\/hep.30429","volume":"70","author":"RS Khan","year":"2019","unstructured":"Khan RS, Bril F, Cusi K, Newsome PN. Modulation of Insulin Resistance in nonalcoholic fatty liver disease. Hepatology. 2019;70:711\u201324.","journal-title":"Hepatology"},{"key":"3228_CR36","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1146\/annurev-pathol-012615-044224","volume":"11","author":"T Hardy","year":"2016","unstructured":"Hardy T, Oakley F, Anstee QM, Day CP. Nonalcoholic fatty liver disease: Pathogenesis and Disease Spectrum. Annu Rev Pathol. 2016;11:451\u201396.","journal-title":"Annu Rev Pathol"},{"key":"3228_CR37","doi-asserted-by":"crossref","unstructured":"Zhang J, Zhou J, He Z, Li H. Bacteroides and NAFLD: pathophysiology and therapy. Front Microbiol. 2024;15.","DOI":"10.3389\/fmicb.2024.1288856"},{"key":"3228_CR38","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jaci.2022.11.007","volume":"151","author":"JK Tan","year":"2023","unstructured":"Tan JK, Macia L, Mackay CR. Dietary fiber and SCFAs in the regulation of mucosal immunity. J Allergy Clin Immunol. 2023;151:361\u201370.","journal-title":"J Allergy Clin Immunol"},{"key":"3228_CR39","doi-asserted-by":"publisher","first-page":"5681","DOI":"10.7150\/ijbs.65044","volume":"18","author":"T Fang","year":"2022","unstructured":"Fang T, Wang H, Pan X, Little PJ, Xu S, Weng J. Mouse models of nonalcoholic fatty liver disease (NAFLD): pathomechanisms and pharmacotherapies. Int J Biol Sci. 2022;18:5681\u201397.","journal-title":"Int J Biol Sci"},{"key":"3228_CR40","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s00535-017-1415-1","volume":"53","author":"Y Sumida","year":"2018","unstructured":"Sumida Y, Yoneda M. Current and future pharmacological therapies for NAFLD\/NASH. J Gastroenterol. 2018;53:362\u201376.","journal-title":"J Gastroenterol"},{"key":"3228_CR41","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3390\/biom9030099","volume":"9","author":"DJ Den Hartogh","year":"2019","unstructured":"Den Hartogh DJ, Tsiani E. Antidiabetic properties of Naringenin: a Citrus Fruit Polyphenol. Biomolecules. 2019;9:99.","journal-title":"Biomolecules"},{"key":"3228_CR42","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/advances\/nmaa106","volume":"12","author":"F Naeini","year":"2021","unstructured":"Naeini F, Namkhah Z, Ostadrahimi A, Tutunchi H, Hosseinzadeh-Attar MJ. A comprehensive systematic review of the effects of Naringenin, a Citrus-Derived Flavonoid, on risk factors for nonalcoholic fatty liver disease. Adv Nutr. 2021;12:413\u201328.","journal-title":"Adv Nutr"},{"key":"3228_CR43","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","volume":"64","author":"EASL","year":"2016","unstructured":"EASL\u2013EASD\u2013EASO Clinical Practice. Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64:1388\u2013402.","journal-title":"J Hepatol"},{"key":"3228_CR44","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1007\/s00125-016-3940-5","volume":"59","author":"JG Jones","year":"2016","unstructured":"Jones JG. Hepatic glucose and lipid metabolism. Diabetologia. 2016;59:1098\u2013103.","journal-title":"Diabetologia"},{"key":"3228_CR45","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1038\/s41401-020-0368-8","volume":"41","author":"Q Qi","year":"2020","unstructured":"Qi Q, Hu W-j, Zheng S-l, Zhang S-l, Le Y-y, Li Z-y. Miao C-y: Metrnl deficiency decreases blood HDL cholesterol and increases blood triglyceride. Acta Pharmacol Sin. 2020;41:1568\u201375.","journal-title":"Acta Pharmacol Sin"},{"key":"3228_CR46","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41387-019-0095-8","volume":"9","author":"S Li","year":"2019","unstructured":"Li S, Zhang Y, Sun Y, Zhang G, Bai J, Guo J, Su X, Du H, Cao X, Yang J, Wang T. Naringenin improves insulin sensitivity in gestational diabetes mellitus mice through AMPK. Nutr Diabetes. 2019;9:28.","journal-title":"Nutr Diabetes"},{"key":"3228_CR47","doi-asserted-by":"crossref","unstructured":"Haas JT, Francque S, Staels B. Pathophysiology and mechanisms of nonalcoholic fatty liver disease. Annu Rev Physiol. 2015;78:181\u2013205.","DOI":"10.1146\/annurev-physiol-021115-105331"},{"key":"3228_CR48","doi-asserted-by":"publisher","first-page":"153755","DOI":"10.1016\/j.phymed.2021.153755","volume":"92","author":"R Jayasuriya","year":"2021","unstructured":"Jayasuriya R, Dhamodharan U, Ali D, Ganesan K, Xu B, Ramkumar KM. Targeting Nrf2\/Keap1 signaling pathway by bioactive natural agents: possible therapeutic strategy to combat liver disease. Phytomedicine. 2021;92:153755.","journal-title":"Phytomedicine"},{"key":"3228_CR49","doi-asserted-by":"publisher","first-page":"100387","DOI":"10.1016\/j.jhepr.2021.100387","volume":"4","author":"J Gillard","year":"2022","unstructured":"Gillard J, Clerbaux LA, Nachit M, Sempoux C, Staels B, Bindels LB, Tailleux A, Leclercq IA. Bile acids contribute to the development of non-alcoholic steatohepatitis in mice. JHEP Rep. 2022;4:100387.","journal-title":"JHEP Rep"},{"key":"3228_CR50","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1161\/CIRCRESAHA.122.321938","volume":"132","author":"BL Clifford","year":"2023","unstructured":"Clifford BL, Jarrett KE, Cheng J, Cheng A, Seldin M, Morand P, Lee R, Chen M, Baldan A, de Aguiar Vallim TQ, Tarling EJ. RNF130 regulates LDLR availability and plasma LDL cholesterol levels. Circ Res. 2023;132:849\u201363.","journal-title":"Circ Res"},{"key":"3228_CR51","doi-asserted-by":"publisher","first-page":"115586","DOI":"10.1016\/j.biopha.2023.115586","volume":"170","author":"Q Sun","year":"2024","unstructured":"Sun Q, Xing X, Wang H, Wan K, Fan R, Liu C, Wang Y, Wu W, Wang Y, Wang R. SCD1 is the critical signaling hub to mediate metabolic diseases: mechanism and the development of its inhibitors. Biomed Pharmacother. 2024;170:115586.","journal-title":"Biomed Pharmacother"},{"key":"3228_CR52","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1146\/annurev.med.53.082901.104057","volume":"53","author":"RH Unger","year":"2002","unstructured":"Unger RH. Lipotoxic diseases. Annu Rev Med. 2002;53:319\u201336.","journal-title":"Annu Rev Med"},{"key":"3228_CR53","doi-asserted-by":"crossref","unstructured":"Guan H, Guo Y, Zhu L, Jiao Y, Liu X. Peroxisome Deficiency Dysregulates Fatty Acid Oxidization and Exacerbates Lipotoxicity in \u03b2 Cells. Oxid Med Cell Longev 2021, 2021:7726058.","DOI":"10.1155\/2021\/7726058"},{"key":"3228_CR54","doi-asserted-by":"crossref","unstructured":"Ravaut G, L\u00e9giot A, Bergeron K-F, Mounier C. Monounsaturated Fatty Acids in Obesity-Related Inflammation. In International Journal of Molecular Sciences, 2021;22.","DOI":"10.3390\/ijms22010330"},{"key":"3228_CR55","doi-asserted-by":"crossref","unstructured":"Keane KN, Cruzat VF, Carlessi R, de Bittencourt PI Jr., Newsholme P. Molecular Events Linking Oxidative Stress and Inflammation to Insulin Resistance and \u03b2-Cell Dysfunction. Oxid Med Cell Longev 2015, 2015:181643.","DOI":"10.1155\/2015\/181643"},{"key":"3228_CR56","doi-asserted-by":"crossref","unstructured":"Gandhi GR, Vasconcelos ABS, Wu DT, Li HB, Antony PJ, Li H, Geng F, Gurgel RQ, Narain N, Gan RY. Citrus flavonoids as promising phytochemicals targeting diabetes and related complications: a systematic review of in vitro and in vivo studies. Nutrients. 2020;12:10.","DOI":"10.3390\/nu12102907"},{"key":"3228_CR57","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.biopha.2017.07.094","volume":"94","author":"OM Ahmed","year":"2017","unstructured":"Ahmed OM, Hassan MA, Abdel-Twab SM, Abdel Azeem MN. Navel orange peel hydroethanolic extract, naringin and naringenin have anti-diabetic potentials in type 2 diabetic rats. Biomed Pharmacother. 2017;94:197\u2013205.","journal-title":"Biomed Pharmacother"},{"key":"3228_CR58","doi-asserted-by":"publisher","first-page":"153818","DOI":"10.1016\/j.phymed.2021.153818","volume":"94","author":"B Zhang","year":"2022","unstructured":"Zhang B, Zeng M, Wang Y, Li M, Wu Y, Xu R, Zhang Q, Jia J, Huang Y, Zheng X, Feng W. Oleic acid alleviates LPS-induced acute kidney injury by restraining inflammation and oxidative stress via the Ras\/MAPKs\/PPAR-\u03b3 signaling pathway. Phytomedicine. 2022;94:153818.","journal-title":"Phytomedicine"},{"key":"3228_CR59","doi-asserted-by":"publisher","first-page":"101428","DOI":"10.1016\/j.molmet.2021.101428","volume":"57","author":"H Zeng","year":"2022","unstructured":"Zeng H, Qin H, Liao M, Zheng E, Luo X, Xiao A, Li Y, Chen L, Wei L, Zhao L, et al. CD36 promotes de novo lipogenesis in hepatocytes through INSIG2-dependent SREBP1 processing. Mol Metabolism. 2022;57:101428.","journal-title":"Mol Metabolism"},{"key":"3228_CR60","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.jhep.2018.04.006","volume":"69","author":"L Zhao","year":"2018","unstructured":"Zhao L, Zhang C, Luo X, Wang P, Zhou W, Zhong S, Xie Y, Jiang Y, Yang P, Tang R, et al. CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis. J Hepatol. 2018;69:705\u201317.","journal-title":"J Hepatol"},{"key":"3228_CR61","doi-asserted-by":"publisher","first-page":"117401","DOI":"10.1016\/j.jep.2023.117401","volume":"320","author":"N Zheng","year":"2024","unstructured":"Zheng N, Wang H, Zhu W, Li Y, Li H. Astragalus polysaccharide attenuates nonalcoholic fatty liver disease through THDCA in high-fat diet-fed mice. J Ethnopharmacol. 2024;320:117401.","journal-title":"J Ethnopharmacol"},{"key":"3228_CR62","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1080\/10408398.2019.1679085","volume":"60","author":"I Najmanov\u00e1","year":"2020","unstructured":"Najmanov\u00e1 I, Vopr\u0161alov\u00e1 M, Saso L, Mlad\u011bnka P. The pharmacokinetics of flavanones. Crit Rev Food Sci Nutr. 2020;60:3155\u201371.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"3228_CR63","doi-asserted-by":"publisher","first-page":"9918","DOI":"10.1039\/D2FO01610A","volume":"13","author":"S Zhang","year":"2022","unstructured":"Zhang S, Li J, Shi X, Tan X, Si Q. Naringenin activates beige adipocyte browning in high fat diet-fed C57BL\/6 mice by shaping the gut microbiota. Food Funct. 2022;13:9918\u201330.","journal-title":"Food Funct"},{"key":"3228_CR64","doi-asserted-by":"publisher","first-page":"7826","DOI":"10.1002\/fsn3.3700","volume":"11","author":"P Cao","year":"2023","unstructured":"Cao P, Yue M, Cheng Y, Sullivan MA, Chen W, Yu H, Li F, Wu S, Lv Y, Zhai X, Zhang Y. Naringenin prevents non-alcoholic steatohepatitis by modulating the host metabolome and intestinal microbiome in MCD diet-fed mice. Food Sci Nutr. 2023;11:7826\u201340.","journal-title":"Food Sci Nutr"},{"key":"3228_CR65","doi-asserted-by":"publisher","first-page":"110945","DOI":"10.1016\/j.foodres.2022.110945","volume":"153","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Xu Y, Zhang L, Chen Y, Wu T, Liu R, Sui W, Zhu Q, Zhang M. Licorice extract ameliorates hyperglycemia through reshaping gut microbiota structure and inhibiting TLR4\/NF-\u03baB signaling pathway in type 2 diabetic mice. Food Res Int. 2022;153:110945.","journal-title":"Food Res Int"},{"key":"3228_CR66","doi-asserted-by":"crossref","unstructured":"Wang B, Kong Q, Li X, Zhao J, Zhang H, Chen W, Wang G. A high-fat diet increases gut microbiota biodiversity and energy expenditure due to nutrient difference. Nutrients. 2020;12:10.","DOI":"10.3390\/nu12103197"},{"key":"3228_CR67","doi-asserted-by":"publisher","first-page":"906","DOI":"10.3389\/fimmu.2020.00906","volume":"11","author":"BJ Parker","year":"2020","unstructured":"Parker BJ, Wearsch PA, Veloo ACM, Rodriguez-Palacios A. The Genus Alistipes: gut Bacteria with emerging implications to inflammation, Cancer, and Mental Health. Front Immunol. 2020;11:906.","journal-title":"Front Immunol"},{"key":"3228_CR68","doi-asserted-by":"crossref","unstructured":"Yu Y, Zeng F, Han P, Zhang L, Yang L, Zhou F, Liu Q, Ruan Z. Dietary chlorogenic acid alleviates high-fat diet-induced steatotic liver disease by regulating metabolites and gut microbiota. Int J Food Sci Nutr 2024:1\u201316.","DOI":"10.1080\/09637486.2024.2318590"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03228-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03228-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03228-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T10:51:32Z","timestamp":1741085492000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03228-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3228"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03228-x","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,4]]},"assertion":[{"value":"1 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were performed in strict accordance with the South China Agricultural University animal ethics committee guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agreed to publish this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"168"}}